MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-12-2026
Harvard Bioscience Total Shareholders Equity 2011-2026 | HBIO
Annual Total Shareholders Equity Harvard Bioscience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.7 M | 63.3 M | 73.1 M | 72.2 M | 83.4 M | 76.7 M | 81.7 M | 82.7 M | 80.9 M | 72.2 M | 77.6 M | 95.5 M | 94.5 M | 104 M | 95.5 M | 90.2 M | 75.3 M | 66.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 104 M | 13.7 M | 77.7 M |
Quarterly Total Shareholders Equity Harvard Bioscience
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 M | 14.1 M | 15.7 M | 14.8 M | 63.3 M | 65.3 M | 67.2 M | 68.8 M | 73.1 M | 74.3 M | 75.4 M | 74.3 M | 72.2 M | 72 M | 77.5 M | 76.4 M | 83.4 M | 76.9 M | 78.7 M | 77.1 M | 76.7 M | 76.7 M | 76.7 M | 76.7 M | 81.7 M | 81.7 M | 81.7 M | 81.7 M | 82.7 M | 82.7 M | 82.7 M | 82.7 M | 80.9 M | 80.9 M | 80.9 M | 80.9 M | 72.2 M | 72.2 M | 72.2 M | 72.2 M | 77.6 M | 77.6 M | 77.6 M | 77.6 M | 95.5 M | 95.5 M | 95.5 M | 95.5 M | 94.5 M | 94.5 M | 105 M | 94.5 M | 104 M | 104 M | 104 M | 104 M | 95.5 M | 95.5 M | 95.5 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 105 M | 10 M | 77.8 M |
Total Shareholders Equity of other stocks in the Medical instruments industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
8.24 B | $ 61.75 | 0.49 % | $ 12.3 B | USA |
 |
ICU Medical
ICUI
|
2.12 B | $ 129.31 | 4.57 % | $ 3.19 B | USA |
 |
Alcon
ALC
|
18.8 B | $ 67.28 | 1.48 % | $ 40.4 B |  Schweiz |
 |
Intuitive Surgical
ISRG
|
17.8 B | $ 449.03 | 1.69 % | $ 160 B | USA |
 |
iRhythm Technologies
IRTC
|
153 M | $ 117.0 | 2.78 % | $ 3.74 B | USA |
 |
Repro Med Systems
KRMD
|
17 M | $ 4.0 | 1.01 % | $ 185 M | USA |
 |
LeMaitre Vascular
LMAT
|
394 M | $ 101.43 | 0.1 % | $ 2.3 B | USA |
 |
Masimo Corporation
MASI
|
1.05 B | $ 178.79 | -0.01 % | $ 9.53 B | USA |
 |
Milestone Scientific
MLSS
|
2.81 M | $ 0.4 | 14.99 % | $ 32.8 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
9.03 M | - | - | $ 28.6 M | USA |
 |
electroCore
ECOR
|
-1.71 M | $ 6.13 | 3.81 % | $ 52 K | USA |
 |
Envista Holdings Corporation
NVST
|
3.11 B | $ 23.77 | 3.15 % | $ 3.99 B | USA |
 |
Haemonetics Corporation
HAE
|
821 M | $ 59.56 | 4.79 % | $ 3 B | USA |
 |
STERIS plc
STE
|
6.6 B | $ 215.97 | 0.67 % | $ 21.3 B | USA |
 |
Isoray
ISR
|
207 M | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
462 M | $ 143.82 | 2.71 % | $ 6.97 B | USA |
 |
STAAR Surgical Company
STAA
|
344 M | $ 33.05 | 1.38 % | $ 1.64 B | USA |
 |
InfuSystem Holdings
INFU
|
57.3 M | $ 10.16 | 5.07 % | $ 210 M | USA |
 |
Microbot Medical
MBOT
|
77.6 M | $ 1.74 | 0.58 % | $ 79.7 M |  Israel |
 |
Teleflex Incorporated
TFX
|
3.12 B | $ 135.18 | 1.81 % | $ 6.03 B | USA |
 |
Utah Medical Products
UTMD
|
119 M | $ 64.17 | 0.27 % | $ 208 M | USA |
 |
Merit Medical Systems
MMSI
|
1.58 B | $ 64.49 | 1.13 % | $ 3.82 B | USA |
 |
West Pharmaceutical Services
WST
|
3.18 B | $ 305.5 | 0.55 % | $ 22.1 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.34 B | $ 9.84 | 1.03 % | $ 1.96 B | USA |
 |
Pulse Biosciences
PLSE
|
80.7 M | $ 26.09 | 4.57 % | $ 1.76 B | USA |
 |
Retractable Technologies
RVP
|
74.4 M | $ 0.66 | -2.35 % | $ 19.8 M | USA |
 |
Pro-Dex
PDEX
|
36.6 M | $ 63.47 | 4.43 % | $ 209 M | USA |
 |
Predictive Oncology
POAI
|
47.7 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
372 M | $ 24.0 | 4.12 % | $ 1.15 B | USA |
 |
Stereotaxis
STXS
|
13.5 M | $ 1.85 | 7.56 % | $ 168 M | USA |
 |
Baxter International
BAX
|
6.13 B | $ 18.77 | 2.37 % | $ 9.63 B | USA |
 |
ResMed
RMD
|
3.36 B | $ 209.86 | 0.98 % | $ 30.7 B | USA |
 |
AtriCure
ATRC
|
492 M | $ 29.0 | 0.69 % | $ 1.38 B | USA |
 |
NeuroMetrix
NURO
|
14.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
183 M | $ 11.81 | 3.23 % | $ 482 M | USA |
 |
Becton, Dickinson and Company
BDX
|
25.4 B | $ 146.95 | 0.02 % | $ 42.3 B | USA |
 |
Nephros
NEPH
|
10.2 M | $ 3.57 | -1.79 % | $ 37.9 M | USA |
 |
OraSure Technologies
OSUR
|
341 M | $ 3.07 | -0.32 % | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
2.11 B | $ 111.74 | 2.97 % | $ 6.28 M | USA |